Aurobindo Pharma receives USFDA approval for Estradiol Vaginal Inserts USP, 10 mcg
The approved product has an estimated market size of US$ 268 million for the twelve months ending June 2024, according to IQVIA
The approved product has an estimated market size of US$ 268 million for the twelve months ending June 2024, according to IQVIA
Approval is based on data from two Phase III studies in branch and central retinal vein occlusion (RVO) showing early and sustained vision improvements non-inferior to aflibercept
Nelarabine is a nucleoside metabolic inhibitor indicated for the treatment of patients with T-cell acute lymphoblastic leukemia
The drug will be manufactured at the group's formulation manufacturing facility in Ahmedabad SEZ - II, India
The company is planning to expand its plant capacity in in Vapi
The approved ANDA is therapeutically equivalent to the reference listed drug product
Sacubitril and Valsartan combination is used to treat chronic heart failure in adults
Dr. Sanjay Behari, Director of Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, as the President of the Medical Assessment and Rating Board
Subscribe To Our Newsletter & Stay Updated